Braskem SA Class A (BAK)
Official siteBASIC MATERIALS • CHEMICALS • NYSE
Market Cap: $450.29M
Last updated: Nov 17, 2026 at 11:04 AM ET
Braskem SA Class A (BAK) Financials: Revenue, Profit and Cash Flow
Braskem SA Class A reported revenue of BRL 69.33B for the fiscal year ended Dec 31, 2025, down 10.4% from the year before. That year, net income was BRL -9.69B with a net margin of -14.0%, operating cash flow was BRL -4.09B and free cash flow was BRL -7.16B. The quarter ended Jun 30, 2026 had revenue of BRL 21.71B and net income of BRL 3.33B.
Revenue and Margins
The operating margin was -5.7% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from BRL 47.66B, a compound annual rate of 4.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 69.33B | -10.4% | 2.2% | -5.7% | -14.0% |
| Dec 2024 | 77.41B | +9.7% | 7.7% | 1.3% | -14.6% |
| Dec 2023 | 70.57B | -26.9% | 4.3% | -2.5% | -6.5% |
| Dec 2022 | 96.52B | -8.6% | 11.8% | 6.3% | -0.3% |
| Dec 2021 | 105.63B | +80.4% | 30.3% | 25.7% | 13.2% |
| Dec 2020 | 58.54B | +11.9% | 19.0% | 12.0% | -11.4% |
| Dec 2019 | 52.32B | -9.8% | 12.3% | 0.3% | -4.9% |
| Dec 2018 | 58.00B | +17.7% | 20.0% | 14.3% | 4.9% |
| Dec 2017 | 49.26B | +3.4% | 26.1% | 19.0% | 8.3% |
| Dec 2016 | 47.66B | N/A | 26.7% | 12.5% | -0.9% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 69.33B | 77.41B | 70.57B | 96.52B | 105.63B | 58.54B | 52.32B | 58.00B | 49.26B | 47.66B |
| Cost of revenue | 67.80B | 71.41B | 67.55B | 85.16B | 73.57B | 47.45B | 45.88B | 46.41B | 36.40B | 34.94B |
| Gross profit | 1.53B | 6.00B | 3.02B | 11.36B | 32.06B | 11.10B | 6.44B | 11.59B | 12.86B | 12.72B |
| Research and development | 450.96M | 463.00M | 383.00M | 374.00M | 297.00M | 250.65M | 247.73M | 199.82M | 167.00M | 162.01M |
| Operating income | -3.95B | 1.01B | -1.75B | 6.11B | 27.18B | 7.02B | 169.09M | 8.30B | 9.36B | 5.95B |
| Net income | -9.69B | -11.32B | -4.58B | -336.00M | 13.98B | -6.69B | -2.54B | 2.87B | 4.08B | -411.47M |
| EBITDA | 631.35M | 3.89B | 3.26B | 8.11B | N/A | 10.95B | 1.94B | 9.27B | 11.54B | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.71B | 15.49B | 16.10B | 17.30B | 17.86B | 19.46B | 19.15B | 21.27B | 19.07B | 17.92B | 16.69B | 16.68B |
| Gross profit | 5.32B | 1.10B | -552.00M | 436.00M | 362.00M | 1.31B | 1.15B | 2.25B | 1.39B | 1.21B | 1.01B | 570.00M |
| Operating income | 4.00B | -217.00M | 113.00M | -929.00M | -958.00M | 99.00M | -301.00M | 1.02B | -158.00M | -41.00M | -980.00M | -613.00M |
| Net income | 3.33B | 1.45B | -10.29B | -26.00M | -267.00M | 698.00M | -5.65B | -593.00M | -3.74B | -1.34B | -1.57B | -2.42B |
Balance Sheet
As of Dec 2025, total debt of BRL 68.06B exceeded cash and equivalents by 57.56B. Shareholder equity was negative, at -16.14B, as total liabilities of 98.33B exceeded total assets of 81.84B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 81.84B | 101.58B | 91.74B | 88.05B | 92.56B | 86.08B | 53.34B | 59.19B | 52.73B | 51.82B |
| Current assets | 30.43B | 37.04B | 37.44B | 34.46B | 39.29B | 34.19B | 17.99B | 21.38B | 17.42B | 16.26B |
| Cash and equivalents | 10.50B | 14.99B | 14.19B | 12.47B | 8.68B | 13.86B | 3.77B | 5.55B | 3.78B | 6.70B |
| Total liabilities | 98.33B | 105.85B | 88.46B | 81.94B | 86.36B | 89.95B | 47.65B | 53.28B | 47.26B | 50.10B |
| Short-term debt | 21.66B | 4.13B | 3.75B | 3.29B | 2.16B | 9.93B | 10.90B | 11.28B | 10.91B | 13.06B |
| Long-term debt | 46.39B | 66.28B | 53.21B | 44.84B | 49.56B | 44.99B | 37.71B | 24.16B | 22.18B | 20.74B |
| Shareholder equity | -16.14B | -4.28B | 3.28B | 6.11B | 6.20B | -3.87B | 5.69B | 5.91B | 5.47B | 1.72B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 79.24B | 74.94B | 81.88B | 87.38B | 91.30B | 95.42B | 101.58B | 92.65B | 97.06B | 93.54B | 91.74B | 92.02B |
| Total liabilities | 92.33B | 90.97B | 98.38B | 90.56B | 94.56B | 99.22B | 105.85B | 94.14B | 98.03B | 91.17B | 88.46B | 87.64B |
| Cash and equivalents | 3.93B | 4.62B | 10.50B | 6.66B | 9.18B | 11.32B | 14.99B | 11.92B | 14.21B | 14.21B | 14.19B | 13.64B |
| Shareholder equity | -12.59B | -15.54B | -16.15B | -3.53B | -3.81B | -4.24B | -4.78B | -25.00M | 85.00M | 3.08B | 3.99B | 5.02B |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -4.09B | 2.44B | -2.27B | 8.95B | 14.79B | 6.29B | 2.27B | 9.25B | 4.75B | 4.75B |
| Capital expenditures | 3.07B | 3.76B | 4.53B | 4.85B | 3.42B | 2.76B | 2.68B | 2.71B | 2.87B | 2.87B |
| Free cash flow | -7.16B | -1.33B | -6.80B | 4.10B | 11.37B | 3.53B | -417.25M | 6.54B | 1.87B | 1.87B |
| Dividends paid | 0 | 6.00M | 7.00M | 1.35B | 5.99B | 2.00M | 668.90M | 1.50B | 2.00B | 2.00B |
| Investing cash flow | -2.94B | -3.48B | -4.53B | -4.95B | -3.38B | -2.72B | -2.67B | -2.49B | -2.84B | -2.84B |
| Financing cash flow | 3.13B | 469.00M | 8.87B | 225.00M | -16.97B | 2.17B | 1.64B | -4.60B | -2.76B | -2.76B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 29.00M | -4.17B | -901.33M | -683.00M | -285.00M | -2.33B | 817.00M | -790.00M | 1.44B | 965.00M | 1.01B | -2.46B |
| Capital expenditures | 564.00M | 661.39M | 582.75M | 1.27B | 648.00M | 653.00M | 1.03B | 840.00M | 1.02B | 870.00M | 1.23B | 1.22B |
| Free cash flow | -535.00M | -4.83B | -1.48B | -1.95B | -933.00M | -2.98B | -215.00M | -1.63B | 425.00M | 95.00M | -220.00M | -3.69B |
Frequently Asked Questions About BAK
What is Braskem SA Class A's annual revenue?
Braskem SA Class A reported revenue of BRL 69.33B for the fiscal year ended Dec 31, 2025.
How fast is Braskem SA Class A's revenue growing?
Revenue was down 10.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -10.4%.
Is Braskem SA Class A profitable?
No. Braskem SA Class A reported net income of BRL -9.69B for the fiscal year ended Dec 31, 2025, with a net margin of -14.0%.
How much free cash flow does BAK generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of BRL -4.09B minus capital expenditures of BRL 3.07B produced free cash flow of BRL -7.16B.
How much debt does Braskem SA Class A have?
The balance sheet dated Dec 31, 2025 reported long-term debt of BRL 46.39B, short-term debt of BRL 21.66B and cash and equivalents of BRL 10.50B.
BAK pages: Overview, Financials, Competitors